GlassScriptPhysician profile
Christine Tompkins
NPI 1922144500
$2,353.20
in general payments reported to CMS, 2019-2025
8 companies · $1,416 in 2025
The $1,416 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $49.94 · 2021: $119 · 2023: $418 · 2025: $1,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,314 · Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,313.91 |
| Food and Beverage | $519.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,652.51 | 2023-2025 | Evera Mri Xt Dr Surescan |
| Biosense Webster, INC. | $233.72 | 2019-2023 | Carto 3 |
| Abbott Laboratories | $174.46 | 2019 | |
| Janssen Pharmaceuticals, INC | $120.40 | 2020-2021 | |
| Boston Scientific Corporation | $102.95 | 2019-2021 | |
| Medtronic Vascular, INC. | $30.42 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.95 | 2025 | Lifevest |
| Philips North America LLC | $15.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Tompkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.